000			02113 a2200577 4500
005			20250517154127.0
264		0	_c20180507
008			201805s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdx266 _2doi
040			_aNLM _beng _cNLM
100	1		_aAli, H R
245	0	0	_aLymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2017
300			_a1832-1835 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBevacizumab _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aComputational Biology
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aEpirubicin _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFluorouracil _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aLymphocyte Count
650	0	4	_aLymphocytes _xpathology
650	0	4	_aLymphocytes, Tumor-Infiltrating _xpathology
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aRemission Induction
700	1		_aDariush, A
700	1		_aThomas, J
700	1		_aProvenzano, E
700	1		_aDunn, J
700	1		_aHiller, L
700	1		_aVallier, A-L
700	1		_aAbraham, J
700	1		_aPiper, T
700	1		_aBartlett, J M S
700	1		_aCameron, D A
700	1		_aHayward, L
700	1		_aBrenton, J D
700	1		_aPharoah, P D P
700	1		_aIrwin, M J
700	1		_aWalton, N A
700	1		_aEarl, H M
700	1		_aCaldas, C
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 28 _gno. 8 _gp. 1832-1835
856	4	0	_uhttps://doi.org/10.1093/annonc/mdx266 _zAvailable from publisher's website
999			_c27192087 _d27192087